Lipofection of insulin-producing RINm5F cells: methodological improvements

Area of Science:

• Biotechnology
• Molecular Biology
• Cell Biology

Background:

• Cationic lipid/DNA complexes are non-viral gene transfer vectors with lower toxicity and immunogenicity.
• Lipofection is a key method for gene delivery into cells, but efficiency can vary.
• Optimizing lipofection for specific cell types, like insulin-producing cells, is crucial for gene therapy applications.

Purpose of the Study:

• To enhance and characterize the lipofection process for an insulin-producing cell line (RINm5F).
• To compare the efficacy of seven commercial lipid formulations for gene transfer.
• To investigate factors influencing lipofection efficiency, including centrifugation, serum presence, and nuclear localization signals.

Main Methods:

• Transfection of RINm5F cells with GFP-expressing plasmids using seven different lipid formulations.
• Flow cytometry analysis to quantify GFP expression and assess transfection efficiency.
• Evaluation of the impact of centrifugation, serum, and a nuclear localization signal peptide on gene transfer.

Main Results:

• GenePORTER and LipofectAMINE demonstrated efficient gene transfer in RINm5F cells.
• GenePORTER showed superior performance by enabling transfection in the presence of serum and exhibiting lower cytotoxicity compared to LipofectAMINE.
• LipofectAMINE-induced cytotoxicity was partially mitigated by TPA, forskolin, or fumonisin beta(1).
• Both centrifugation and the inclusion of a nuclear localization signal peptide significantly improved transfection efficiency.

Conclusions:

• GenePORTER is a highly effective and advantageous lipid formulation for gene delivery into insulin-producing cells, particularly in serum-containing media.
• Optimization strategies such as centrifugation and nuclear localization signals can further enhance gene transfer efficiency.
• These findings contribute to the development of improved non-viral gene therapy approaches for diabetes treatment.